GABELLI DIVIDEND & INCOME TRUST 8-K

What Happened

• Gabelli Dividend & Income Trust (GDV) filed an 8-K (filed May 7, 2026) reporting that Mario J. Gabelli — Trustee, Chairman and Chief Investment Officer of the Fund and Chairman, Co‑CEO and Chief Investment Officer — Value Portfolios of GAMCO Investors, Inc. — experienced a medical incident on March 19, 2026 and was admitted to the hospital for observation and testing on March 23, 2026. His condition is improving, but no return timeline has been provided.
• On March 22, 2026 GAMCO (the parent of the Fund’s adviser, Gabelli Funds, LLC) implemented a succession plan in place for several years and named Christopher J. Marangi President of GAMCO. Day‑to‑day operations will be led by co‑CEO Douglas R. Jamieson and Christopher J. Marangi.

Key Details

• Medical incident occurred March 19, 2026; hospital admission on March 23, 2026; condition described as improving.
• Succession plan implemented March 22, 2026; Christopher J. Marangi named President of GAMCO.
• Portfolio management for the Fund during Mr. Gabelli’s absence is being led by Gabelli Value team Co‑Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi.
• 8-K filing date: May 7, 2026 (Accession: 0001829126-26-004781).

Why It Matters

• Leadership continuity: The adviser implemented a preexisting succession plan and assigned clear interim leaders, which helps maintain daily operations and portfolio management without disruption.
• For investors this means the Fund’s investment team remains in place (co‑CIOs Dreyer and Marangi) and the adviser’s management responsibilities are covered, reducing operational risk while Mr. Gabelli recovers.
• The filing provides facts only — Mr. Gabelli’s return date is unknown, so investors should monitor future filings or company updates for any changes.